For the Inventor, By the Inventor

Enter assignee name

Plymouth, MN, United States of America

Aga Medical Corporation

USPTO Granted Patents = 48

% Expired Patents = 31.3

CIPO Patents = 12

EPO Patents = 20

Trademarks = 4

Forward Citations = 9,355

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Kurt Amplatz (25 out of 62 patents)

John C Oslund (13 out of 69 patents)

Xiaoping Gu (9 out of 34 patents)

4. Michael R Afremov (8 out of 11 patents)

5. Patrick P Russo (6 out of 18 patents)

6. Daniel O Adams (6 out of 86 patents)

7. Curtis Amplatz (5 out of 10 patents)

8. Matthew Charles Heidner (5 out of 22 patents)

9. Jana Santer (3 out of 11 patents)

10. Brooke Ren (3 out of 26 patents)

11. Mathias Charles Glimsdale (2 out of 27 patents)

12. Matt Glimsdale (2 out of 20 patents)

13. Derek Wise (2 out of 13 patents)

14. Sara Jane Gries (2 out of 3 patents)

15. Ryan Kariniemi (2 out of 9 patents)

Core Competencies:

Intravascular Occlusion

Percutaneous Catheter

Vascular Defects

Stent Graft

Occlusion Device

Multi-layer Structures

Flow Restrictor

Medical Device

Deployment Method

Braided Structures

Septal Defect

Aneurysm Treatment

48 patents: Sort by Forward Citations

1. 11116486 - Percutaneous catheter directed intravascular occlusion devices (2021-09-14),

2. 10973523 - Medical device for treating a target site (2021-04-13),

3. 10149669 - Percutaneous catheter directed intravascular occlusion devices (2018-12-11),

4. 9232992 - Multi-layered medical device for treating a target site and associated method (2016-01-12),

5. 9179920 - Occlusion device and associated deployment method (2015-11-10),

6. 9113890 - Devices and methods for occluding vascular abnormalities (2015-08-25),

7. 9039752 - Device and method for delivering a vascular device (2015-05-26),

8. 9039724 - Device for occluding vascular defects (2015-05-26),

9. 8961556 - Percutaneous catheter directed intravascular occlusion devices (2015-02-24),

10. 8940015 - Asymmetrical medical devices for treating a target site and associated method (2015-01-27),

11. 8919389 - Tubular structure and method for making the same (2014-12-30),

12. 8900287 - Intravascular deliverable stent for reinforcement of abdominal aortic aneurysm (2014-12-02),

13. 8821529 - Device and method for occluding a septal defect (2014-09-02),

14. 8778008 - Intravascular deliverable stent for reinforcement of vascular abnormalities (2014-07-15),

15. 8777974 - Multi-layer braided structures for occluding vascular defects (2014-07-15),

Company Overview

Aga Medical Corporation, based in Plymouth, MN, specializes in the development and manufacturing of innovative medical devices focused on intravascular occlusion. The company is recognized for its expertise in addressing vascular abnormalities through advanced technologies such as percutaneous catheters and stent grafts. Their product offerings include occlusion devices designed to treat various vascular defects, utilizing sophisticated braided structures to enhance performance and reliability in clinical applications.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

48 Patents

#12 in Plymouth, MN

#204 in Minnesota

#7,284 in US

#14,550 in the World

Plymouth, MN, United States of America

Aga Medical Corporation

Forward Citations = 9,355

30 inventors:

Kurt Amplatz (25 out of 62 patents)

John C Oslund (13 out of 69 patents)

Xiaoping Gu (9 out of 34 patents)

4. Michael R Afremov (8 out of 11 patents)

5. Patrick P Russo (6 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aga Medical Corporation. Retrieved from https://idiyas.com/company/aga-medical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…